BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 10605005)

  • 1. CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression.
    Appleman LJ; Berezovskaya A; Grass I; Boussiotis VA
    J Immunol; 2000 Jan; 164(1):144-51. PubMed ID: 10605005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.
    Appleman LJ; van Puijenbroek AA; Shu KM; Nadler LM; Boussiotis VA
    J Immunol; 2002 Mar; 168(6):2729-36. PubMed ID: 11884439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD28 induces cell cycle progression by IL-2-independent down-regulation of p27kip1 expression in human peripheral T lymphocytes.
    Boonen GJ; van Dijk AM; Verdonck LF; van Lier RA; Rijksen G; Medema RH
    Eur J Immunol; 1999 Mar; 29(3):789-98. PubMed ID: 10092081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of proteasomes in T cell activation and proliferation.
    Wang X; Luo H; Chen H; Duguid W; Wu J
    J Immunol; 1998 Jan; 160(2):788-801. PubMed ID: 9551914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-free degradation of p27(kip1), a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome.
    Nguyen H; Gitig DM; Koff A
    Mol Cell Biol; 1999 Feb; 19(2):1190-201. PubMed ID: 9891053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of T lymphocytes from elderly humans to enter the cell cycle is associated with low Cdk6 activity and impaired phosphorylation of Rb protein.
    Arbogast A; Boutet S; Phelouzat MA; Plastre O; Quadri R; Proust JJ
    Cell Immunol; 1999 Oct; 197(1):46-54. PubMed ID: 10555995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
    Benaud CM; Dickson RB
    Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anchorage dependence of mitogen-induced G1 to S transition in primary T lymphocytes.
    Geginat J; Bossi G; Bender JR; Pardi R
    J Immunol; 1999 May; 162(9):5085-93. PubMed ID: 10227977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of p18INK4 and p27kip1 cyclin-dependent kinase inhibitors is regulated differently during human B cell differentiation.
    Schrantz N; Beney GE; Auffredou MT; Bourgeade MF; Leca G; Vazquez A
    J Immunol; 2000 Oct; 165(8):4346-52. PubMed ID: 11035070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis for the lack of T cell proliferation induced by an altered peptide ligand.
    Grakoui A; VanDyk LF; Dowdy SF; Allen PM
    Int Immunol; 1998 Jul; 10(7):969-79. PubMed ID: 9701035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diacylglycerol kinase inhibition prevents IL-2-induced G1 to S transition through a phosphatidylinositol-3 kinase-independent mechanism.
    Flores I; Jones DR; Ciprés A; Díaz-Flores E; Sanjuan MA; Mérida I
    J Immunol; 1999 Jul; 163(2):708-14. PubMed ID: 10395661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kip1 degradation via the ubiquitin-proteasome pathway.
    Tam SW; Theodoras AM; Pagano M
    Leukemia; 1997 Apr; 11 Suppl 3():363-6. PubMed ID: 9209391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
    Vlach J; Hennecke S; Amati B
    EMBO J; 1997 Sep; 16(17):5334-44. PubMed ID: 9311993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the cell cycle at the G1-S transition by proteolysis of cyclin E and p27Kip1.
    Nakayama KI; Hatakeyama S; Nakayama K
    Biochem Biophys Res Commun; 2001 Apr; 282(4):853-60. PubMed ID: 11352628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aging impairs induction of cyclin-dependent kinases and down-regulation of p27 in mouse CD4(+) cells.
    Tamir A; Miller RA
    Cell Immunol; 1999 Nov; 198(1):11-20. PubMed ID: 10612647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered T-cell receptor + CD28-mediated signaling and blocked cell cycle progression in interleukin 10 and transforming growth factor-beta-treated alloreactive T cells that do not induce graft-versus-host disease.
    Boussiotis VA; Chen ZM; Zeller JC; Murphy WJ; Berezovskaya A; Narula S; Roncarolo MG; Blazar BR
    Blood; 2001 Jan; 97(2):565-71. PubMed ID: 11154238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTLA-4 regulates cell cycle progression during a primary immune response.
    Greenwald RJ; Oosterwegel MA; van der Woude D; Kubal A; Mandelbrot DA; Boussiotis VA; Sharpe AH
    Eur J Immunol; 2002 Feb; 32(2):366-73. PubMed ID: 11807776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting edge: p27Kip1 deficiency reduces the requirement for CD28-mediated costimulation in naive CD8+ but not CD4+ T lymphocytes.
    Wolfraim LA; Letterio JJ
    J Immunol; 2005 Mar; 174(5):2481-4. PubMed ID: 15728451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The identification of a novel T cell activation state controlled by a diabetogenic gene.
    Moore JK; Scheinman RI; Bellgrau D
    J Immunol; 2001 Jan; 166(1):241-8. PubMed ID: 11123298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative-feedback regulation of CD28 costimulation by a novel mitogen-activated protein kinase phosphatase, MKP6.
    Marti F; Krause A; Post NH; Lyddane C; Dupont B; Sadelain M; King PD
    J Immunol; 2001 Jan; 166(1):197-206. PubMed ID: 11123293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.